Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

M Kvist Reimer, Jens Juul Holst, B Ahrén

178 Citations (Scopus)

Abstract

OBJECTIVES: Inhibitors of the glucagon-like peptide-1 (GLP-1)-degrading enzyme, dipeptidyl peptidase IV (DPPIV), are being explored in the treatment of diabetes. We examined the long-term influence of a selective, orally active inhibitor of DPPIV (NVP DPP728), in normal female C57BL/6J mice and such mice rendered glucose-intolerant and insulin-resistant by feeding a high-fat diet.

DESIGN: In mice fed a standard diet (11% fat) or a high-fat diet (58% fat), NVP DPP728 (0.12 micromol/g body weight) was administered in the drinking water for an 8 week period.

RESULTS: DPPIV inhibition reduced plasma DPPIV activity to 0.01+/-0.03 mU/ml vs 3.26+/-0.19 mU/ml in controls (P<0.001). Glucose tolerance after gastric glucose gavage, as judged by the area under the curve for plasma glucose levels over the 120 min study period, was increased after 8 weeks by NVP DPP728 in mice fed normal diet (P=0.029) and in mice fed a high-fat diet (P=0.036). This was accompanied by increased plasma levels of insulin and intact GLP-1. Glucose-stimulated insulin secretion from islets isolated from NVP DPP728-treated animals after 8 weeks of treatment was increased as compared with islets from control animals at 5.6, 8.3 and 11.1 mmol/l glucose both in mice fed normal diet and in mice fed a high-fat diet (both P<0.05). Islet insulin and glucagon immunocytochemistry revealed that NVP DPP728 did not affect the islet architecture. However, the expression of immunoreactive glucose transporter isoform-2 (GLUT-2) was increased by DPPIV inhibition, and in mice fed a high-fat diet, islet size was reduced after treatment with NVP DPP728 from 16.7+/-2.6 x 10(3) microm(2) in controls to 7.6+/-1.0 x 10(3) microm(2) (P=0.0019).

CONCLUSION: Long-term DPPIV inhibition improves glucose tolerance in both normal and glucose-intolerant mice through improved islet function as judged by increased GLUT-2 expression, increased insulin secretion and protection from increased islet size in insulin resistance.

Original languageEnglish
JournalEuropean Journal of Endocrinology. Supplement
Volume146
Issue number5
Pages (from-to)717-27
Number of pages11
ISSN0804-4643
Publication statusPublished - May 2002

Keywords

  • Animals
  • Blood Glucose
  • Body Weight
  • Dietary Fats
  • Dipeptidyl Peptidase 4
  • Drinking
  • Eating
  • Female
  • Glucagon
  • Glucagon-Like Peptide 1
  • Glucose
  • Glucose Intolerance
  • Insulin
  • Insulin Resistance
  • Intubation, Gastrointestinal
  • Islets of Langerhans
  • Mice
  • Mice, Inbred C57BL
  • Nitriles
  • Organ Size
  • Peptide Fragments
  • Protease Inhibitors
  • Protein Precursors
  • Pyrrolidines
  • Time Factors

Fingerprint

Dive into the research topics of 'Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice'. Together they form a unique fingerprint.

Cite this